Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from Operating Activities
Net loss	$ (1,581,298)	$ (1,338,639)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	22,241	56,194
Warrant expense	37,984	27,765
Option expense	357,053	100,366
Amortization of debt discount
Changes in operating assets and liabilities:
Inventory	(4,131)	22,666
Prepaid expense and other current assets	(5,544)	67,400
Accounts payable and accrued expenses	261,674	54,844
Accrued interest – related party	2,545	206
Customer deposits
Net cash used in operating activities	(909,476)	(1,009,198)
Cash flows from Investing Activities
Investment in patents	(11,469)	(2,369)
Capital expenditures	(1,638)	(4,908)
Net cash used in investing activities	(13,107)	(7,277)
Cash flows from Financing Activities
Cash received from stock subscription
Proceeds from private placement offering, net	125,048	401,250
Advances from investors		48,729
Proceeds from convertible note payable – related party
Repayment on convertible note payable – related party	(70,080)	(195,000)
Net cash provided by financing activities	54,968	254,979
Net change in cash	(867,615)	(761,496)
Cash and cash equivalents at beginning of period	1,276,654	2,038,150
Cash and cash equivalents at end of period	409,039	1,276,654
Supplemental Cash Flow Information
Cash paid for interest	903	3,818
Cash paid for income taxes
Non-Cash Transactions
Stock issued for accrued liabilities	69,500	116,250
Stock issued for subscription		85,791
Conversion of debt to common stock	100,000	178,125
Reversal of accrued dividends		34,280
Stock issued for advances from investors	$ 100,635	$ 721,035